CSF monoamine metabolites in relation to the diagnostic interview for borderline patients (DIB)

Neuropsychobiology

Volumn 38, Issue 4, 1998, Pages 207-212

  Chotai, Jayanti ^a,c   Kullgren, Gunnar ^a   Åsberg, Marie ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Lycksele Hospital   (Sweden)

Author keywords

Borderline personality disorder; Diagnostic Interview for Borderline patients; Impulsivity; Monoamine metabolites

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; HOMOVANILLIC ACID; MONOAMINE;

ARTICLE; BORDERLINE STATE; CEREBROSPINAL FLUID; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; METABOLITE; MOOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SUICIDAL BEHAVIOR;

BIOGENIC MONOAMINES; BORDERLINE PERSONALITY DISORDER; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; METHOXYHYDROXYPHENYLGLYCOL; MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES;

EID: 0031793778     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026542     Document Type: Article

References (28)

1. Zimmerman M: Diagnosing personality disorders. A review of issues and research methods. Arch Gen Psychiatry 1994;51:225-245.
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington, APA, 1987.
3. Gunderson JG, Kolb JE, Austin V: The diagnostic interview for borderline patients. Am J Psychiatry 1981;138:896-903.
4. Loranger AW, Oldham JM, Russakoff LM, Susman V: Structured interviews and borderline personality disorder. Arch Gen Psychiatry 1984;41:565-568.
5. Frances A, Clarkin JF, Gilmore M, Hurt SW, Brown R: Reliability criteria for borderline personality disorder: A comparison of DSM-III and the Diangostic Interview for Borderline patients. Am J Psychiatry 1984;141:1080-1084.
6. Nelson HF, Tennen H, Tasman A, Borton M, Kubeck M, Stone M: Comparison of three systems for diagnosing borderline personality disorder. Am J Psychiatry 1985;142:855-858.
7. Kullgren G: An empirical comparison of three different borderline concepts. Acta Psychiatr Scand 1987;76:246-255.
8. Kavoussi RJ, Coccaro EF, Klar HM, Berstein D, Siever LJ: Structured interviews for borderline personality disorder. Am J Psychiatry 1990;147:1522-1525.
9. Lewis SJ, Harder DW: A comparison of four measures to diagnose DSM-III-R borderline personality disorder in outpatients. J Nerv Ment Dis 1991;179:329-337.
10. Weston SC, Siever LJ: Biologic correlates of personality disorders. J Pers Disord 1993; (suppl): 129-148.
11. Åsberg M, Träskman L, Thorén P: 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch Gen Psychiatry 1976;33: 1193-1197.
12. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF: Aggression in humans correlates with cerebropsinal fluid amine metabolites. Psychiatry Res 1979;1:131-139.
13. Brown GL, Ebert MH, Goyer PF, Jimerson DC, Klein WJ, Bunney WE, Goodwin FK: Aggression, suicide, and serotonin: Relationships to CSF amine metabolites. Am J Psychiatry 1982;139:741-746.
14. Åsberg M, Schalling D, Träskman-Bendz L, Wägner A: Psychobiology of suicide, impulsivity, and related phenomena: in Meltzer HY (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 655-668.
15. Nordström P, Samuelsson M, Åsberg M, Träskman-Bendz L, Åsberg-Wistedt A, Nordin C, Bertilsson L: CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 1994;24:1-9.
16. Linnoila M, Virkunnen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK: Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 1983;33:2609-2614.
17. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bisette G, Kalogeras K, Karonen SL, Linnoila M: CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 1994;51:20-27.
18. Roy A: Recent biological studies on suicide. Suicide Life Threat Behav 1994;24:10-14.
19. Åsberg M, Bertilsson L, Mårtensson B, Scalia-Tomba GP, Thorén P, Träskman-Bendz L: CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 1984;69:201-219.
20. Bertilsson L: Quantitative mass fragmentography - a valuable tool in clinical pharmacology; in Usdin E (ed): Clinical Pharmacology in Psychiatry. New York. Elsevier, 1981, pp 59-72.
21. Gunderson JG: Empirical studies of borderline diagnosis; in Grinspoon L (ed): Psychiatry 1982, Annual Review. Washington, American Psychiatric Association, 1982.
22. McGlashan T: The borderline syndrome. I. Testing three diagnostic systems. Arch Gen Psychiatry 1983;40:1311-1318.
23. Armelius BÅ, Kullgren G, Renberg E: Borderline diagnosis from hospital records. Reliability and validity of Gunderson's Diagnostic Interview for Borderlines (DIB). J Nerv Ment Dis 1985;173:32-34.
24. Gardner DL, Lucas PB, Cowdry RW: CSF metabolites in borderline personality disorder compared with normal controls. Biol Psychiatry 1990;28:247-254.
25. Hollander E, Stein DJ, Concetta MD, Cohen L, Saoud JB, Skodol AE, Kellman D, Rosnick L, Oldham JM: Serotonergic sensitivity in borderline personality disorder: Preliminary findings. Am J Psychiatry 1994;151:277-280.
26. Ogiso Y, Moriya N, Ikuta N, Maher-Nishizono A, Takase M, Miyake Y, Minakawa K: Relationship between clinical symptoms and EEG findings in borderline personality disorder. Jpn J Psychiatr Neurol 1993;47:37-46.
27. Lahmeyer HW, Val E, Gaviria FM, Prasad B, Pandey GN, Rodgers P, Weiler MA, Altman EG: EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder. Psychiatry Res 1988;25:19-30.
28. Higley JD, Mehlman PT, Higley SB, Fernald B, Vickers J, Lindell SG, Taub DM, Suomi SJ, Linnoila M: Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Arch Gen Psychiatry 1996;53: 537-543.